financetom
Business
financetom
/
Business
/
BofA doubles banking team in Switzerland amid shifting regulatory landscape
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BofA doubles banking team in Switzerland amid shifting regulatory landscape
Feb 12, 2025 7:57 AM

Feb 12 (Reuters) - Bank of America ( BAC ) has doubled

its banking team in Switzerland, seizing on a potential

opportunity to gain market share as bigger Swiss rivals deal

with tougher regulation.

Switzerland has pledged to put in place stricter banking

rules since the 2023 collapse of Credit Suisse, which was then

taken over by UBS. At the center of the overhaul are

plans to make UBS hold more capital to prevent a repeat of the

crisis.

"Recently, with the disruption that went on in Switzerland,

we added some bankers to build our team there," Bank of America ( BAC )

CEO Brian Moynihan said at a conference on Wednesday, adding

that the size of the team doubled "pretty quickly".

The Swiss government has said it wants stricter capital

requirements for UBS and its three biggest peers - PostFinance,

Raiffeisen and Zürcher Kantonalbank.

In December, UBS CEO Sergio Ermotti said tougher regulation

across the board could weaken the Swiss financial sector against

competition. He said on Monday that doesn't expect "much clarity

until May."

BofA's international business is overseen by Bernard Mensah,

who also heads Merrill Lynch International.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'
Sanofi Shocker: CEO Paul Hudson Out As Board Demands 'Increased Rigor'
Mar 11, 2026
Sanofi SA ( SNY ) on Wednesday decided not to renew the Director mandate of Paul Hudson. As a result, Paul Hudson's last day as Chief Executive Officer will be on February 17, 2026, after his tenure of six years with the company. Succession Plan And Governance Actions The Board of Directors appointed Belén Garijo as Chief Executive Officer. She...
West Pharmaceutical Q4 Non-GAAP Earnings, Sales Rise; 2026 Guidance Set -- Shares Up Pre-Bell
West Pharmaceutical Q4 Non-GAAP Earnings, Sales Rise; 2026 Guidance Set -- Shares Up Pre-Bell
Mar 11, 2026
06:24 AM EST, 02/12/2026 (MT Newswires) -- West Pharmaceutical Services ( WST ) reported Q4 non-GAAP earnings Thursday of $2.04 per diluted share, up from $1.82 a year earlier. Analysts polled by FactSet expected $1.83. Net sales for the quarter ended Dec. 31 were $805 million, up from $748.8 million a year earlier. Analysts surveyed by FactSet expected $794.9 million....
Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways
Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways
Mar 11, 2026
MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group (DIG) today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing a significant ownership position in PetMed Express, Inc. (PetMed or the Company). DIG believes PetMed's current share price is materially disconnected from the Company's intrinsic value. With multiple...
GEO Group Q4 Adjusted Earnings, Revenue Rise; Initiates 2026 Guidance
GEO Group Q4 Adjusted Earnings, Revenue Rise; Initiates 2026 Guidance
Mar 11, 2026
06:28 AM EST, 02/12/2026 (MT Newswires) -- GEO Group ( GEO ) reported Q4 adjusted net income Thursday of $0.25 per diluted share, up from $0.13 a year earlier. Four analysts surveyed by FactSet expected $0.24. Revenue for the quarter ended Dec. 31 was $707.7 million, compared with $607.7 million a year earlier. Analysts polled by FactSet expected $667.3 million....
Copyright 2023-2026 - www.financetom.com All Rights Reserved